DV EQUITIES, LLC

Position in NVO — Novo Nordisk A S

CIK 1841659 CHICAGO, IL

Position in NVO

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$30,260,974

+$16,547,492 QoQ

Shares Held

631,226

+134.2% QoQ

Ownership

0.014%

of shares outstanding

% of Portfolio

7.30%

of 13F equity value

Holder Rank

#74

of 1,348 holders

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

DV EQUITIES, LLC holds $40,243,259 across 3 Drug Manufacturers - General names. NVO ranks #1 (75.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NVO	Novo Nordisk A S This page	631,226	$30,260,974
2	GSK	GSK plc	188,762	$9,894,904
3	GRFS	Grifols SA	12,342	$87,381

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$30,260,974	631,226	+134.2%	Shares	Other	2026-08-14
2025-12-31	$13,713,482	269,526	—	Shares	Other	2026-02-17
No filing history on record for this holder in this stock.